logo
logo

Israeli Medical Device Startup, Innoventric Ltd., Wins The Prestigious Horizon Europe Grant And Secures Us $14M In Series A Investment

Nov 01, 2021•over 3 years ago

Round Type

series a

Description

Innoventric, a start-up company from Ness-Ziona, Israel, develops the unique TrilliumTM technology for the treatment of Tricuspid Valve Regurgitation. The company was founded in 2017, and has rapidly progressed. Innoventric has performed over 10 implantations of the promising TrilliumTM technology as part of its European first in human clinical trial. The company holds a broad patent portfolio for the TrilliumTM and additional Tricuspid technologies.

Company Information

Company

Innoventric Ltd

About

The company holds a broad patent portfolio for the Trillium™ and additional Tricuspid technologies. Four years ago, the company raised its seed investment from two Leading Israeli MedTech venture capitals. Recently, the company secured $14M through its Series A financing, this includes the prestigious Horizon Europe Grant for the sum of €2.5M. The winning companies receive a grant that is intended to support the company growth.